Study examines multivessel mortality rates

December 29, 2011 in Cardiology
UAlbany Study Examines Multivessel Mortality Rates

Enlarge

A new study led by School of Public Health Distinguished Professor Emeritus Edward Hannan raises concerns about the use of bare metal stents for patients with multivessel disease.

(Medical Xpress) -- A new study led by University at Albany School of Public Health Distinguished Professor Emeritus Edward L. Hannan finds a link between higher mortality rates and incomplete revascularization procedures for patients suffering from multivessel disease.

According to a population-based study published in Circulation: , for patients who receive percutaneous coronary intervention (PCI) with (BMS) -- a commonly used revascularization procedure for patients with coronary artery disease -- incomplete revascularization (IR) is associated with higher mortality risk as late as eight years after treatment.

The team studied 13,016 patients with multivessel who underwent BMS implantation between 1999 and 2000. The researchers discovered that complete revascularization (CR), in which all diseased vessels have been successfully stented, occurred in only 29.2 percent of patients.

Hannan's team examined the eight-year survival rate of patients with IR vs. CR patients. The respective 8-year survival rates were 78.5 percent for IR patients and 80.8 for CR patients, respectively. The risk of death was higher for IR patients.

The study concludes that IR may be associated with a higher risk of mortality during long-term follow-up after coronary stenting with BMS in patients with multivessel disease.

"These findings should be considered in determining how PCI is performed and in selecting the most appropriate means of revascularization, such as PCI or ," said Hannan.

Provided by University at Albany

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • Force in a magnetic coupling
    created9 hours ago
  • Sign of scalar product in electric potential integral?
    created16 hours ago
  • Heat engines: how can we yield work?
    created17 hours ago
  • Work done by us on the spring
    createdMay 25, 2012
  • Surface current density
    createdMay 25, 2012
  • Work done on body moving in a circle
    createdMay 25, 2012
  • More from Physics Forums - Classical Physics

More news stories

One-fifth of healthy middle-aged men have low-grade murmur

(HealthDay) -- More than one-fifth of healthy middle-aged men have a low-grade systolic heart murmur that confers a nearly five-fold higher risk of future aortic valve replacement (AVR), according to a study ...

Cardiology created May 25, 2012 | popularity not rated yet | comments 0

New device allows pacemaker patients to safely undergo MRIs

For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.

Cardiology created May 25, 2012 | popularity not rated yet | comments 0 | with audio podcast

New study should end debate over magnesium treatment for preventing poor outcome after haemorrhagic stroke

An international randomised trial and meta-analysis published Online First in The Lancet should put an end to the debate about the use of intravenous magnesium sulphate to prevent poor outcomes after haemorrhagic stroke. The in ...

Cardiology created May 25, 2012 | popularity not rated yet | comments 0

Low vitamin D in diet increases stroke risk in Japanese-Americans

Japanese-American men who did not eat foods rich in vitamin D had a higher risk of stroke later in life, according to results of a 34-year study reported in Stroke, an American Heart Association journal.

Cardiology created May 24, 2012 | popularity not rated yet | comments 0

Clot buster seems to help up to 6 hours after stroke

(HealthDay) -- The largest study of its kind finds that stroke patients benefit from a clot-busting drug even six hours after a stroke, suggesting that the current recommended 4.5-hour limit could be expanded.

Cardiology created May 24, 2012 | popularity not rated yet | comments 0


Travel to high altitudes tied to Crohn's, colitis flare-ups

(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...

Family history of Alzheimer's affects functional connectivity

(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...

Transvaginal mesh op restores pelvic organ prolapse at price

(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...

Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Weight struggles? Blame new neurons in your hypothalamus

New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.